United Therapeutics
UTHR
554.73
-4.37
-0.78%
United Therapeutics
US · UTHR
#836 by market cap
Listed 1970
554.73
-4.37
-0.78%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About United Therapeutics
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
- Founded
- 1996
- CEO
- Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD
- Employees
- 1,400
- Headquarters
- Silver Spring, Maryland, United States of America
- Fiscal year end
- 12-31
- Website
- unither.com
Company profile
- Exchange
- US
- Symbol
- UTHR
- Market-cap rank
- #836
- Listing date
- 1970-01-01
- Market cap
- 23.63B
- Float cap
- 21.60B
- Shares out
- 42.59M
- Float shares
- 38.94M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-11-20 20:02:22 · For reference only, not investment advice and not tailored to your situation.
United Therapeutics discussion 0 comments